Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 4th:
Cassava Sciences, Inc. (SAVA - Free Report) : This clinical-stage drug development company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 28.9% over the last 60 days.
Cassava Sciences’ shares gained 31.8% over the last one month above the S&P 500’s increase0.5%. The company possesses a Momentum Score of B.
China Automotive Systems, Inc. (CAAS - Free Report) : This manufacturer and seller of automotive systems and components has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 87.5% over the last 60 days.
China Automotive Systems’ shares gained 93.4% over the last one month. The company possesses a Momentum Score of B.
Galmed Pharmaceuticals Ltd. (GLMD - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 13.9% over the last 60 days.
Galmed Pharmaceuticals’ shares gained 18.8% over the last one month. The company possesses a Momentum Score of B.
Globalstar, Inc. (GSAT - Free Report) : This provider of mobile satellite voice and data communication services has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Globalstar’s shares gained 0.5% over the last one month. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 4th:
Cassava Sciences, Inc. (SAVA - Free Report) : This clinical-stage drug development company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 28.9% over the last 60 days.
Cassava Sciences’ shares gained 31.8% over the last one month above the S&P 500’s increase0.5%. The company possesses a Momentum Score of B.
China Automotive Systems, Inc. (CAAS - Free Report) : This manufacturer and seller of automotive systems and components has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 87.5% over the last 60 days.
China Automotive Systems’ shares gained 93.4% over the last one month. The company possesses a Momentum Score of B.
Galmed Pharmaceuticals Ltd. (GLMD - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 13.9% over the last 60 days.
Galmed Pharmaceuticals’ shares gained 18.8% over the last one month. The company possesses a Momentum Score of B.
Globalstar, Inc. (GSAT - Free Report) : This provider of mobile satellite voice and data communication services has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Globalstar’s shares gained 0.5% over the last one month. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on CAAS - FREE
Get the latest research report on GSAT - FREE
Get the latest research report on GLMD - FREE
Get the latest research report on SAVA - FREE